Umbilical cord blood cells for low blood counts after immune therapy
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study tests whether umbilical cord blood cells can help people whose blood counts stay dangerously low after immune-based cancer treatments like CAR-T or bispecific antibodies. The treatment aims to boost your blood cell recovery and reduce the need for transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have received CAR-T therapy or bispecific antibody therapy (a type of cancer treatment that uses your immune system).
- After that treatment, your blood counts (white blood cells, red blood cells, or platelets) must have stayed very low for at least 3 weeks, even with standard treatment.
- You must not have had or be planning to have a stem cell transplant using your own cells.
- You must be willing to sign a consent form and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if umbilical cord stem cells can help restore low blood counts in people with leukemia, lymphoma, or myeloma who still have low blood cell levels three weeks after CAR-T therapy. It aims to improve recovery and reduce infection or bleeding risks.
This trial tests if giving back your own stored stem cells can help restore low blood cell counts that persist or develop 30 to 90 days after CAR-T therapy for multiple myeloma.
This study tests whether umbilical cord blood cells can help patients whose blood counts have dropped again after a stem cell transplant. It may be an option for people who have recovered initially but later develop low blood cell levels.
This trial tests whether infusing stem cells from umbilical cord blood can help your bone marrow recover and make healthy blood cells again after chemotherapy. The goal is to improve your blood counts and reduce the need for transfusions.
This trial tests whether umbilical cord blood can help raise platelet levels in people whose platelets drop after cancer treatment. If it works, it might reduce the need for platelet transfusions and lower bleeding risk.
This study tests whether giving children their own or donor umbilical cord blood cells after chemotherapy can help their blood counts recover faster, allowing the next chemo round to start sooner. It's for children with solid tumors that have come back or not responded to treatment.
Hear when a new Refractory Immune Effector Cell-related Hemocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.